RxSight (RXST) Common Equity (2020 - 2026)
RxSight's (RXST) quarterly Common Equity came in at $267.3 million in Q1 2026, down 4.3% YoY from $279.3 million in Q1 2025, and down 3.04% on a QoQ basis from $275.7 million in Q4 2025.
RxSight (RXST) Common Equity (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Common Equity data on file, last reported at $267.3 million in Q1 2026.
- Quarterly Common Equity fell 4.3% year-over-year to $267.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $267.3 million (down 4.3% YoY) and the FY2025 annual result came in at $275.7 million, down 1.98% from the prior year.
- Common Equity retreated to $267.3 million in Q1 2026, from $275.7 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $281.2 million in Q4 2024 to a low of $89.9 million in Q4 2022.
- A 5-year average of $201.0 million and a median of $163.9 million in 2024 frame the typical range for Common Equity.
- The widest YoY moves for Common Equity: up 140.8% in 2022, down 36.41% in 2022.
- Tracing RXST's Common Equity over 5 years: stood at $89.9 million in 2022, then jumped by 78.37% to $160.4 million in 2023, then jumped by 75.38% to $281.2 million in 2024, then dropped by 1.98% to $275.7 million in 2025, then dropped by 3.04% to $267.3 million in 2026.
- The last three Common Equity figures came in at $267.3 million (Q1 2026), $275.7 million (Q4 2025), and $276.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 7.22 Bn |
| 10 | RxSight | 254.75 Mn | -149.49 Mn | - | 263.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 263.34 Mn |
| Mar 31, 2026 | 267.30 Mn |
| Dec 31, 2025 | 275.68 Mn |
| Sep 30, 2025 | 275.97 Mn |
| Jun 30, 2025 | 278.01 Mn |
| Mar 31, 2025 | 279.32 Mn |
| Dec 31, 2024 | 281.24 Mn |
| Sep 30, 2024 | 277.26 Mn |
| Jun 30, 2024 | 275.21 Mn |
| Mar 31, 2024 | 163.93 Mn |
| Dec 31, 2023 | 160.36 Mn |
| Sep 30, 2023 | 161.48 Mn |
| Jun 30, 2023 | 157.19 Mn |
| Mar 31, 2023 | 145.01 Mn |
| Dec 31, 2022 | 89.90 Mn |
| Sep 30, 2022 | 95.96 Mn |
| Jun 30, 2022 | 109.99 Mn |
| Mar 31, 2022 | 123.16 Mn |
| Dec 31, 2021 | 138.24 Mn |
| Sep 30, 2021 | 150.89 Mn |